Memantine normalizes brain activity in the inferior frontal gyrus: A controlled pilot fMRI study

Schizophrenia Research

Volumn 97, Issue 1-3, 2007, Pages 294-296

  Cerullo, Michael A ^a   Nasrallah, Henry A ^a   Eliassen, James C ^a   Adler, Caleb M ^a   Nasrallah, Amelia T ^a   Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OLANZAPINE; RISPERIDONE; ZIPRASIDONE;

ALZHEIMER DISEASE; ATTENTION DISTURBANCE; BRAIN MAPPING; BRAIN REGION; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LETTER; NEUROIMAGING; NEUROTRANSMISSION; PARIETAL LOBE; PRIORITY JOURNAL; SCHIZOPHRENIA; WORKING MEMORY;

ADULT; ANTIPSYCHOTIC AGENTS; DOMINANCE, CEREBRAL; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMANTINE; MENTAL RECALL; PARIETAL LOBE; PILOT PROJECTS; SCHIZOPHRENIA;

EID: 36049031183     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.07.034     Document Type: Letter

References (10)

1. Fletcher P., McKenna P., Frith C., Grasby P., Friston K., and Dolan R. Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging. Arch. Gen. Psychiatry 55 (1998) 1001-1008
2. Harvey P., and Keefe R. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am. J. Psychiatr. 158 (2001) 176-184
3. Hashimoto K. The NMDA receptor hypofunction hypothesis for schizophrenia and glycine modulatory sites on the NMDA receptors as potential therapeutic drugs. Clin. Psychopharmacol. Neurosci. 4 1 (2006) 3-10
4. Heinrichs R., and Zakzanis K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 3 (1998) 426-445
5. Javitt D. Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 78 (2007) 69-108
6. Lawrence N., Ross T., Hoffmann R., Garavan H., and Stein E. Multiple neuronal networks mediate sustained attention. J. Cogn. Neurosci. 15 7 (2003) 1028-1038
7. Lewis D., and Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma aminobutyric acid and glutamate alterations. Neurol. Rev. 63 10 (2006) 1372-1376
8. Manoach D. Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr. Res. 60 (2003) 285-298
9. Thermenos H., Goldstein J., Buka S., Poldrack R., Koch J., Tsuang M., and Seidman L. The effect of working memory performance on functional MRI in schizophrenia. Schizophr. Res. 74 (2005) 179-194
10. Tomasi D., Ernst T., Caparelli E., and Chang L. Common deactivation patterns during working memory and visual attention tasks: an intra-subject fMRI study at 4 tesla. Hum. Brain Mapp. 27 8 (2006) 694-705